Difference between revisions of "LncRNAWiki:E"
| Line 100: | Line 100: | ||
|EXTL3 antisense RNA 1 | |EXTL3 antisense RNA 1 | ||
|_ | |_ | ||
| + | |- | ||
| + | |''ELF3-AS1'' | ||
| + | |[[ELF3-AS1]] | ||
| + | |ENST00000415582 | ||
| + | |ELF3 antisense RNA 1 | ||
| + | |Papillary Thyroid Cancer | ||
|} | |} | ||
Latest revision as of 09:13, 29 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| EGFR-AS1 | EGFR-AS1 | N/A | EGFR antisense RNA 1 | _ |
| EGOT | NONHSAT087635 | "EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947" | Eosinophil granule ontogeny (EGO) RNA | breast cancer |
| ELFN1-AS1 | ELFN1-AS1 | N/A | ELFN1 antisense RNA 1 | _ |
| EMX2OS | lnc-PDZD8-3:1 | "EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847" | Emx2 opposite strand transcript. | _ |
| ENTPD3-AS1 | ENTPD3-AS1 | FLJ36665 | ENTPD3 antisense RNA 1 | _ |
| EPB41L4A-AS1 | EPB41L4A-AS1 | TIGA1 | EPB41L4A antisense RNA 1 | cancer |
| EPB41L4A-AS2 | EPB41L4A-AS2 | FLJ11235 | EPB41L4A antisense RNA 2 (head to head) | _ |
| ERC2-IT1 | ERC2-IT1 | Po42 | ERC2 intronic transcript 1 | _ |
| ERICD | Lnc-CHRAC1-2:1 | "TCONS_00014875, ERIC" | E2F1-regulated inhibitor of cell death (non-protein coding) | _ |
| ERICH1-AS1 | ERICH1-AS1 | N/A | ERICH1 antisense RNA 1 | _ |
| ESRG | ENST00000583516.1 | HESRG | embryonic stem cell related (non-protein coding) | embryonal carcinoma, intracranial aneurism |
| Evf2 | lnc-DLX5-3:1 | "Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764" | _ | _ |
| EWSAT1 | EWSAT1 | FLJ33768 | Ewing sarcoma associated transcript 1 | Ewing sarcoma |
| EXOC3-AS1 | EXOC3-AS1 | N/A | EXOC3 antisense RNA 1 | _ |
| EXTL3-AS1 | EXTL3-AS1 | N/A | EXTL3 antisense RNA 1 | _ |
| ELF3-AS1 | ELF3-AS1 | ENST00000415582 | ELF3 antisense RNA 1 | Papillary Thyroid Cancer |
